Any Need for Preoperative Cardiac Testing in Intermediate-Risk Patients With Tight Beta-Adrenergic Blockade?Editorials published in the Journal of American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology

In addition a small prospective randomized trial that compared atorvastatin versus placebo for patients undergoing major vascular surgery (21) demonstrated an 18% reduction (8% vs. 26%, respectively) in cardiac death, nonfatal MI, and ischemic stroke in the group that received atorvastatin. [...]whether the observed beneficial perioperative risk prevention effect demonstrated by Poldermans et al. [...]the real message here is that patients with stable coronary artery disease, receiving effective medical therapy, have low risk.